Medical Encyclopedia

Merkel Cell Carcinoma

A rare, aggressive skin cancer where immunotherapy has dramatically improved outcomes. This guide explains viral connection, risk factors, diagnosis, and modern treatment strategies.

Medical research
Not medical advice. Any new or unusual skin nodule, especially on sun-exposed areas, warrants evaluation by a dermatologist.
At a Glance

Quick Overview

Rare Cancer

Approximately 2,500-3,000 new cases annually in the United States. [NCI, 2024]

Viral Connection

80% of cases associated with Merkel cell polyomavirus (MCPyV). Virus alone doesn't cause cancer but increases risk. [ACS, 2024]

Older Adults & Immunocompromised

Median age at diagnosis is 70-75 years. Higher rates in HIV patients and transplant recipients. [NCI, 2024]

Immunotherapy Revolution

Checkpoint inhibitors (avelumab, pembrolizumab) have dramatically improved survival. FDA-approved for both early and advanced disease. [NCCN, 2024]

Understanding the Basics

What Is Merkel Cell Carcinoma?

Merkel cell carcinoma (MCC) is a rare, highly aggressive neuroendocrine skin cancer. It presents as a painless, firm nodule, usually on sun-exposed skin of older adults. About 80% are associated with Merkel cell polyomavirus (MCPyV), though the virus alone doesn't cause cancer — additional factors are needed. [NCI, 2024]

The discovery of effective immunotherapy (checkpoint inhibitors) has transformed MCC from a highly fatal disease to one with dramatically improved outcomes. Newer treatment options offer hope where few existed a decade ago.

Finding the Answer

Diagnosis & Staging

Biopsy & Pathology

Any suspicious skin nodule is biopsied. Pathology shows characteristic small blue cells. Immunohistochemistry confirms neuroendocrine markers. [ACS, 2024]

MCPyV & Molecular Testing

MCPyV status is determined by PCR or immunohistochemistry. MCPyV-positive tumors may have better prognosis and different treatment response patterns. [NCI, 2024]

Imaging & Sentinel Lymph Node Biopsy

CT or PET-CT assesses for metastasis. Sentinel lymph node biopsy is standard to stage nodal involvement. [NCCN, 2024]

Staging

Stage I/II: localized disease. Stage III: lymph node involvement. Stage IV: distant metastasis. Early-stage disease often treated curatively with surgery + radiation + immunotherapy. [ACS, 2024]

Your Options

Treatment for Merkel Cell Carcinoma

Surgery

Wide local excision is standard. Removal of lymph nodes (sentinel or complete inguinal lymphadenectomy) is performed for staging and treatment. [NCCN, 2024]

Radiation Therapy

Often used adjuvantly after surgery to reduce recurrence risk, especially for stage II-III disease. Highly effective for MCC. [ACS, 2024]

Immunotherapy (Checkpoint Inhibitors)

Avelumab (FDA-approved for stage I/II after surgery and for advanced disease) and pembrolizumab are standard of care. These drugs unleash the immune system to attack cancer. [NCI, 2024]

Chemotherapy

For advanced/metastatic disease not amenable to surgery or radiation. Often carboplatin + etoposide. Now often combined with or sequenced with immunotherapy. [NCCN, 2024]

Clinical Trials

New immunotherapy combinations and other approaches are being studied. Clinical trials are important given the rapid evolution of MCC treatment. [NCI, 2024]

Evidence Base

Sources & References

  1. American Cancer Society (ACS). "Merkel Cell Carcinoma Overview." Cancer.org. Accessed 2024.
  2. National Cancer Institute (NCI). "Merkel Cell Carcinoma Treatment (PDQ)." Cancer.gov. Accessed 2024.
  3. National Comprehensive Cancer Network (NCCN). "NCCN Guidelines: Merkel Cell Carcinoma." Version 1.2024.

Last reviewed: February 2025. Not medical advice. Always consult your care team.